Publication process
- Confirm the exact product identity: brand/generic name, ingredient, dosage form, strength, pack and target market.
- Record the primary source, document version and publication or effective date; a search snippet never replaces the source document.
- Separate a labelled amount from “how an individual should use it”, and separate a historical record from current supply.
- Check bilingual wording, links, mobile layout, text enlargement and sensitive-information boundaries before publication.
- A broken source, label update or reproducible reader concern sends the page back to review.
View a published dossier example →
Source hierarchy
For a specific medicine, approval status, labelling, package identity and safety updates are checked first against a regulator's formal record or official label. Research and medical context may use peer-reviewed journals and public bodies such as WHO or NIH; the page must retain directly reviewable source routes.
Byline and review role
Published material currently uses the organisational byline “OriginDrug Content Editorial”. “Public primary-source verification” means that the source, target market, product-identity fields and link were checked editorially; it is not a claim of clinical licensure, prescribing authority, diagnosis or individual pharmacy service. A named professional reviewer appears only after consent and verification of affiliation, credentials and conflicts. See the current team and review-role disclosure.
Corrections
If you identify an error in fact, link or wording, use the contact and correction process with the exact page, primary source and reason. We log and verify the concern and update the page and review date where warranted; useful correction history is not silently removed.